Back to Ovarian Cancer
NCT00465725
NCT00465725
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with a solid tumour cancer (not a blood cancer), confirmed by a tissue sample or biopsy.
- Your doctor believes there are no standard treatments left available for you, and that the trial drug (picoplatin) may be an appropriate option.
- You are 18 years of age or older.
- You are reasonably active and able to care for yourself, with only limited or no restrictions on daily activities (confirm with trial site).
- Your doctor estimates you have a life expectancy of at least 12 weeks.
Who may not be able to join:
- You have cancer that has spread to the brain and is causing symptoms, or is not being controlled with treatment.
- You have previously had radiation therapy covering a large portion (30% or more) of your bone marrow.
- You have a serious ongoing medical condition that could make it unsafe for you to participate in the trial.
- You have had stomach or bowel surgery that could affect how your body absorbs a tablet or oral medication.
- You have an active stomach or bowel condition, such as inflammatory bowel disease, gastritis, ulcers, or bleeding in the digestive tract.
- There is evidence that your pancreas has been damaged or that you have active pancreatic inflammation.
- You are currently pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 1
Sponsor
Poniard Pharmaceuticals
Registry
clinicaltrials_gov
Start date
1 April 2007
Est. completion
1 July 2009
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
MTD; Comparison of platinum levels excreted in urine from 0-8 and 8-24 hours after start of IV or oral drug
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.